Novo Nordisk A/S ADR buy fenjal
Start price
29.05.23
/
50%
€154.00
Target price
29.05.24
-
Performance (%)
10.06%
End price
16.08.23
€169.50
Summary
This prediction ended on 16.08.23 with a price of €169.50. The BUY prediction by fenjal finished with a performance of 10.06%. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Novo Nordisk A/S ADR | -3.306% | -3.306% | -18.467% |
iShares Core DAX® | 1.280% | 1.027% | 11.234% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% |
According to fenjal what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by fenjal for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy Novo Nordisk A/S ADR
In the thread Trading Novo Nordisk A/S ADR
Buy beendet
Stopped prediction by fenjal for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.03
09.05.17
09.05.17
€42.00
18.09.17
18.09.17
10.53%
18.09.17
18.09.17
Could be worthwhile Investment >10% per year